Bio.com News & Updates

newsletter at bio.com newsletter at bio.com
Wed Feb 6 20:01:59 EST 2002


Bio.com News & Updates

February 7, 2002
>From Bio Online, Inc.
The Life Sciences Portal(tm)
www.bio.com | www.bioprotocol.com

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

CONTENTS:
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

1.  Science News: =93Immune Protein is Potential Drug Target=94
2.  InFocus: =93Real-Time PCR: Emerging Applications=94
3.  Career Fair: Genome 2002 Tri-Conference Career Fair Exhibition
4.  Investment Research: Introducing Btech Investor
5.  Market Research:  =93Scientific and Medical Journals on the Web=94
6.  Jobs of the Week: =93Research Associate=94 and others

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D


This newsletter is sponsored by:  The BioWorld 2002 Genomics Review

The BioWorld 2002 Genomics Review is a 300-page market report
that provides comprehensive profiles of more than 200 public and
private companies, including the major international players and
small start-ups.  The report also includes details on more than 1,000
genomics collaborations.  Order this top-selling report today.
Go to http://www.ahcpub.com/57441.html to order.=20


=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
1.  SCIENCE NEWS
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

-Is Biologist Barry Commoner a Mutant?
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D1
Longtime radical activist and biologist Barry Commoner has just published a
preposterous article in the February 2002 issue of Harper=92s  that purport=
s
to call into question the "foundation of genetic engineering." Commoner
claims to have uncovered a scandal at the heart of biology and biotechnolog=
y
that the leading researchers and greedy corporations are keeping hidden fro=
m
an unwitting public.

-RNAi: More to RNA than Meets the Eye
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D2
Ask a leading molecular biologist to name the latest buzzword in biomedical
research, and the answer may surprise you. It =92s not genomics, proteomics=
,
or systems biology, but a term seldom heard in the popular press=97RNAi.

-Entrepreneurs and Hindsight Bias: It's Not Easy to Remember What We
Remember
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D3
When you're reading about why a biotech business failed, don't you often
think to yourself, "I could have turned that company around"? You do, don't
you? And haven't you found yourself shaking your head in wonder at how
people could have invested in those dot bombs? Haven't you said to yourself=
,
"I could have seen that crash coming a mile away"?

-Better Biotechnology Market Modeling: Balancing Simplicity and Complexity
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D4
Biotechnology executives frequently must make strategic marketing decisions
based on limited information. Models that emphasize simplicity and
adaptability yet capture the essence of a strategic issue can provide
valuable assistance to decision-makers.

-Immune Protein is Potential Drug Target
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D5
Researchers studying a protein implicated in the development of lupus and
rheumatoid arthritis have discovered a unique domain crucial to the=20
protein=92s function. The findings, reported in the February 8, 2002=20
issue of Cell, provide insight into an important immune-system protein=20
and suggest that the protein may one day serve as a target for autoimmune
therapy.

-Miniaturization of the "Bionic Man"
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D6
Bionic limb replacements that look and work exactly like the real thing wil=
l
likely remain a Hollywood fantasy, but fast advances in human-to-machine
communication and miniaturization could bring the technology close within a
decade.

-Next Generation Biomaterials Heal Body
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D7
Writing in a review in the February 8, 2002 issue of the journal Science,
Professors Larry Hench and Julia Polak of Imperial College, London,
highlight the potential of 'third generation' biomaterials that activate
specific cells and genes of the individual they are implanted into.

-Direct View of Membrane Fusion Within Cells
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D8
Findings published in the February 8, 2002 issue of the journal Cell reveal
a new mechanism of membrane fusion, a process that is essential for such
life functions as nerve impulse transmission or hormone secretion in humans=
.


To view all news, visit http://bio.com/news/research/

To view Industry news, visit http://bio.com/news/pr/


=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
2.  INFOCUS WEBCAST
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

Our next InFocus Webcast, "Real-Time PCR: Emerging Applications" is
scheduled for Wednesday, February 13 at 1 pm Pacific Time.

As cost-effective, flexible real-time PCR platforms become increasingly
available, this powerful tool is moving beyond the domain of core=20
laboratory facilities.Widespread access to real-time PCR is giving rise=20
to a host of innovative applications, including gene expression and=20
pathogen detection. This webcast will explore using this technique to=20
tackle a variety of problems requiring the speed, accuracy and=20
sensitivity that only real-time PCR can offer.

Join us for a live discussion featuring these leaders in the field of
real-time PCR:

-Tony Godfrey, Ph.D.
Assistant Professor of Surgery at the University of Pittsburgh Medical
Center, Departments of Surgery and Human Genetics.

-Norman Schaad, Ph.D.
Research Plant Pathologist (bacteriologist) with the USDA/Agricultural
Research Service, Foreign Disease-Weed Science Research Unit, Ft.=20
Detrick, MD.

-David Norwood, Ph.D.
Assistant Chief of Systems, Development Branch, Diagnostic Systems Division=
,
for the U.S. Army Medical Research Institute of Infectious Disease
(USAMRIID).

Sponsored by Cepheid (http://www.smartcycler.com/)

*For more information, go to:
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D9

*For information on how to tune in to the live webcast, go to:
http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=3D10

*To view past InFocus Webcast recordings and transcripts, go to:
http://www.bio.com/newsfeatures/newsfeatures_fochives.jhtml

*Bio.com's InFocus Webcast, "DNA Microarrays: Platforms and
Applications," was broadcast Wednesday, December 12, 2001.

To read the pdf transcript of this webcast, go to:
http://www.bio.com/file_temp/platapps.pdf


=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
3.  CAREER FAIR:  GENOME 2002 TRI-CONFERENCE CAREER FAIR EXHIBITION
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

Bio.com and Cambridge Healthtech Institute
Genome 2002 Tri-Conference Career Fair Exhibition
http://www.bio.com/careercenter/careercenter_jobfair.jhtml

-Date:
February 23, 2002

-Location:
Santa Clara Convention Center
5001 Great America Parkway
Santa Clara, CA 95054

-Fee:
Your Resume

The Tri-Con Career Fair, organized by CHI and bio.com, provides job seekers
with a forum to interact with hiring managers and human resource=20
professionals from some of the world=92s leading biotech and pharmaceutical
organizations.  This is a first rate tool for matching your skills with the
right organization.  Put yourself on the fast track with some of the hottes=
t
careers in the genomics industry; attend the Tri-Con Career Fair. =20

In order to make your job searching experience more efficient and
productive, please bring several copies of your resume with you. =20
The career fair is free to all attendees. =20

Click here to pre-register for the event:
http://www.bio.com/careercenter/careercenter_jf_cambridgereg.jhtml


=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
4.  INVESTMENT RESEARCH
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

Bio.com is pleased to welcome Btech Investor and SCO Financial Group
as bio.com content partners.

Btech Investor provides consulting on the biotechnology industry to
the financial and biotechnology communities and publishes the Btech
Investor Reports and Btech Investor News.

For an example of Btech Investor's reports on the biotech industry,
go to:
http://www.bio.com/Redirectors/LinkRedirect01_03.jhtml?link=3D10

To purchase a subscription to Btech investor, or to browse and/or
purchase individual reports, visit the bio.com store:
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D10

SCO Financial Group, a registered investment advisor focused on
identifying emerging growth companies in the healthcare sectors,
has made its investment research available, for free, to online
investors at Bio.com.

For an example, read their latest report on Connetics:
http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3D11

For more investment research from SCO Financial Group, go to:
http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=3D11


=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
5.  MARKET RESEARCH
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

Bio.com offers the most comprehensive collection of market research
available on the web. Check out these latest additions:

-Marketing to Life Scientists: Keys to Success
http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=3D12
This report is designed to help marketing professionals optimize their
marketing mix in the academic, industrial and government segments of the
life sciences market.

-Scientific and Medical Journals on the Web
http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=3D13
This major study examines the complex issues facing Scientific, Technical &
Medical (STM) publishers as they confront the fast changing landscape of
electronic publishing.

-Functional Proteomics: Short-Cuts to Drug Discovery
http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=3D14
Technical innovations that can dramatically reduce the time required to
develop new therapeutics are driving the emergence of a new research field
called functional proteomics, and companies engaging in this research could
see huge growth in coming years.

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
6.  JOBS OF THE WEEK
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

Look at what's new on Bio.com Career Center this week:

1.  Gilead Sciences:  Manager, Clinical Data Programming
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D775949&action=3D=
View

2.  QLT Inc:  Quality Control Analyst II
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D776672&action=3D=
View

3.  Pharmaceutical Product Development (PPD):  Manager of=20
Programming/Biostatistics
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D776839&action=3D=
View

4.  Perlegen Sciences:  Research Associate
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D775379&action=3D=
View

5.  Great Smokies Diagnostics Laboratories: Technical Manager/Genomics &
Molecular Biology
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D776401&action=3D=
View

6.  Biotechnology Company (Manufacturing):  Applied Microbiologist
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D776676&action=3D=
View

7.  Research Company:  Cancer Immunotherapy Scientist
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D776711&action=3D=
View

8.  Biotechnology Corporation:  Director of Pharmacology
http://career.bio.com/pages/jobsearch.cfm?object=3D5&job=3D776781&action=3D=
View


Browse all jobs at http://career.bio.com/pages/featured.cfm?1


=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
This message is sent to <arrays at net.bio.net> per your request
To unsubscribe, simply hit Reply from this email account <arrays at net.bio.ne=
t>
and put the word 'unsubscribe' in the subject field.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Copyright =A9 2002, Bio Online.  All rights reserved.

---





More information about the Arrays mailing list